Effect Of Rilapladib (SB-659032) On Platelet Aggregation

Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects

NCT02502812 ·Status: COMPLETED ·Phase: PHASE1

ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"

NCT00360386 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism

NCT00891670 ·Status: UNKNOWN ·Phase: PHASE3

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

NCT00391872 ·Status: COMPLETED ·Phase: PHASE3

Effects of Edoxaban on Platelet Aggregation

NCT05122455 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

NCT00404781 ·Status: COMPLETED ·Phase: PHASE4

Mixed Antagonist of Serotonin for Claudication Optimal Therapy

NCT00300339 ·Status: COMPLETED ·Phase: PHASE2

Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.

NCT01011257 ·Status: WITHDRAWN ·Phase: PHASE4

Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)

NCT00728156 ·Status: COMPLETED ·Phase: PHASE4

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

NCT00862420 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects

NCT01123824 ·Status: COMPLETED ·Phase: PHASE1

Healthy Volunteer Study of Clopidogrel and Rifampicin

NCT00696566 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects

NCT03496506 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

NCT01557335 ·Status: COMPLETED ·Phase: PHASE1

PACT (Platelet Activity After Clopidogrel Termination)

NCT00619073 ·Status: COMPLETED ·Phase: NA

Chewing Clopidogrel in Addition to Regular Oral Clopidogrel Treatment to Improve Platelets Aggregation in Patient With NON ST ELEVATION MI

NCT00889044 ·Status: UNKNOWN ·Phase: PHASE3

Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)

NCT01108588 ·Status: COMPLETED ·Phase: PHASE1

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients

NCT03078257 ·Status: UNKNOWN ·Phase: PHASE1

Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

NCT06223607 ·Status: RECRUITING

Reversibility of Dual Antiplatelet Therapy by Platelets

NCT01248351 ·Status: COMPLETED ·Phase: PHASE2

The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A

NCT00004564 ·Status: UNKNOWN ·Phase: NA

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

NCT00528411 ·Status: COMPLETED ·Phase: PHASE2

Platelet Function Assessment for Atherothrombotic Patients

NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation

NCT00325390 ·Status: COMPLETED ·Phase: PHASE3

Antiplatelet Resistance Research in Patients With Peripheral Arterial Revascularization

NCT03953547 ·Status: COMPLETED